Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1987-02-10
1989-11-07
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
530324, 530325, 530326, 530327, 435 7, 436811, 422 61, C12Q 170, G01N 3353
Patent
active
048792128
ABSTRACT:
The present invention relates to a method for the detection and diagnosis of AIDS (acquired immune deficiency syndrome) ARC (AIDS Related Complex) and pre-AIDS conditions in body fluids by the use of a chemically synthesized peptide composition. The detection method includes an enzyme-linked immunosorbent assay (ELISA), an immunoradiometric assay (IRMA), and other forms of immuno assay procedures such as enzyme immuno blotting assay on nitrocellulose paper and hemagglutination assay using the peptide composition as the antigen. The preferred detection method is ELISA.
The present invention also relates to a vaccine and a method for generating antibodies to HTLV-III in healthy mammals, including humans by the use of the chemically synthesized peptide composition.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 4629783 (1986-12-01), Cosand
Coffin et al., Nature 321, p. 10 (May 1986).
Jungkind et al., "Effect of Using Heat-Inactivated Serum with the Abbott Human T-Cell Lymphotropic Virus Type III Antibody Test", J. Clin. Microbiol. 23:381-382 (Feb. 1986).
Chang et al., "Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic Peptide", Bio/Technology 3:905-909 (Oct. 1985).
Veronese etal., "Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene", Science 229:1402-1405 (Sep. 27, 1985).
Robey et al., "Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients", Science 228:593-595 (May 3, 1985).
Crowl et al., "HTLV-III env Gene Products Synthesized in E. coli are Recognized by Antibodies Present in the Sera of AIDS Patients", Cell 41:979-986 (Jul. 1985).
Schneider et al., "A Glycopolypeptide (gp 100) is the Main Antigen Detected by HTLV-III Antisera", Med. Microbiol. Immunol. 174:35-42 (1985).
Schupbach et al., "Antibodies to HTLV-III in Swiss Patients with AIDS and Pre-AIDS and in Groups at Risk for AIDS", N. Engl. J. Med. 312:265-270 (Jan. 31, 1985).
Wang et al., "Detection of Antibodies to Human T-Lymphotropic Virus Type III by Using a Synthetic Peptide of 21 Amino Acid Residues Corresponding to a Highly Antigenic Segment of gp41 Envelope Protein", Proc. Natl. Acad. Sci. U.S.A. 83:6159-6163 (Aug. 1986).
Schneider et al., "Shedding and Interspecies Type Sero-Reactivity of the Envelope Glycopolypeptide gp120 of the Human Immunodeficiency Virus", J. Gen. Virol. 67:2533-2538 (1986).
Chanh et al., "Induction of Anti-HIV Neutralizing Antibodies by Synthetic Peptides", EMBO J. 5:3065-3071 (Nov. 1986).
Matthews et al., "Restricted Neutralization of Divergent Human T-Lymphotropic Virus Type III Isolates by Antibodies to the Major Envelope Glycoprotein", Proc. Natl. Acad. Sci. U.S.A. 83:9709-9713 (Dec. 1986).
Lange et al., "Distinct IgG Recognition Patterns During Progression of Subclinical and Clinical Infection with Lyphadenopathy Associated Virus/Human T Lyphotropic Virus", Br. Med. J. 292:228-230 (Jan. 25, 1986).
Pert et al., "Octapeptides Deduced from the Neuropeptide Receptor-Like Pattern of Antigen T4 in Brain Potently Inhibit Human Immunodeficiency Virus Receptor Binding and T-Cell Infectivity", Proc. Natl. Acad. Sci. U.S.A. 83:9254-9258 (Dec. 1986).
Certa et al., "Subregions of a Conserved Part of the HIV gp41 Transmembrane Protein are Differentially Recognized by Antibodies of Infected Individuals", EMBO J. 5:3051-3056 (Nov. 1986).
Robey et al., "Prospect for Prevention of Human Immunodeficiency Virus Infection: Purified 120-kDa Envelope Glycoprotein Induces Neutralizing Antibody", Proc. Natl. Acad. Sci. U.S.A. 83:7023-7027 (Sep. 1986).
Chanh et al., "Human Immunodeficiency Virus gp120 Glycoprotein Detected by a Monoclonal Antibody to a Synthetic Peptide", Eur. J. Immunol. 16:1465-1468 (1986).
Starcich et al., "Identification and Characterization of Conserved and Variable Regions in the Envelope Gene of HTLV-III/LAV, the Retrovirus of AIDS", Cell 45;637-648 (Jun. 6, 1986).
Kanner et al., "Human Retroviral env and gag Polypeptides: Serologic Assays to Measure Infection", J. Immunol. 137:674-678 (Jul. 15, 1986).
Chassagne et al., "A Monoclonal Antibody Against LAV gag Precursor: Use for Viral Protein Analysis and Antigenic Expression in Infected Cells", J. Immunol. 136:1442-1445 (Feb. 15, 1986).
Chang et al., Nature, vol. 315, pp. 151-154 (May 9, 1985).
Pauletti et al., Anal. Biochem., 151, 540-546 (1985).
Wang Chang Y.
Wang James J. G.
Nucker Christine M.
United Biomedical Inc.
LandOfFree
Peptide composition and method for the detection of antibodies t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide composition and method for the detection of antibodies t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide composition and method for the detection of antibodies t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-83339